GlaxoSmithKline Pharma Q3 Profit Jumps 29% to Rs 296 Cr

• GlaxoSmithKline Pharmaceuticals reported a 29% increase in consolidated profit after tax for Q3 FY25.
• Profit reached Rs 296 crore for the quarter ended December 31, 2025, up from Rs 230 crore last fiscal.
• Revenue from operations rose to Rs 1,041 crore, compared to Rs 949 crore in the year-ago period.
• The company attributed its performance to competitive efforts amid macro environment and supply mitigation.
• New Labour Codes had no material impact; shares closed 1.01% up on BSE.